These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 5407318)
21. [Therapy of liver diseases, possibilities and problems]. Renger F Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):9-13. PubMed ID: 4100481 [No Abstract] [Full Text] [Related]
22. [Hepagrisevit forte in chronic liver diseases]. Kollatz E; Kramer A; Schopper W; Siede W Med Klin; 1965 Dec; 60(50):2032-5. PubMed ID: 5331151 [No Abstract] [Full Text] [Related]
23. [Clinical work on a new drug combination used in liver diseases and its consequences]. Naufal J Hospital (Rio J); 1969 Apr; 75(4):1469-82. PubMed ID: 5306437 [No Abstract] [Full Text] [Related]
24. [Effects of parenteral administration of hepatotropic preparation with dynamotropic properties in patients with liver diseases]. Rottini E; Scianaro L Clin Ter; 1969 Oct; 51(1):49-61. PubMed ID: 5364033 [No Abstract] [Full Text] [Related]
25. [Considerations on the therapy of viral hepatitis]. Moggi C; Frangini V Clin Ter; 1968 Dec; 47(5):477-83. PubMed ID: 5706853 [No Abstract] [Full Text] [Related]
26. [Report on the experiences in the ambutant treatment of hepatopathy with Heparhormforte]. Ignatius A Landarzt; 1965 Sep; 41(25):1090-2. PubMed ID: 5857646 [No Abstract] [Full Text] [Related]
28. [Studies on the use of liver extracts enriched with uridine, cytidine and vitamin B 12 in pediatric therapy]. Rizzo A Minerva Pediatr; 1971 May; 23(18):803-10. PubMed ID: 5090393 [No Abstract] [Full Text] [Related]
29. [Controlled clinical research with cobamamide in the treatment of viral hepatitis]. Medina F; Vitali D Clin Ter; 1968 Jul; 46(2):139-44. PubMed ID: 5704843 [No Abstract] [Full Text] [Related]
30. [Cholesterolemic changes after treatment with a new hepatoprotective drug in geriatric patients]. Baldoni E; Floris E; Nuzzo L G Gerontol; 1968 Aug; 16(8):785-7. PubMed ID: 5740953 [No Abstract] [Full Text] [Related]
31. [Hepatoprotective action of total liver extract combined with vitamin B 12 vitamin E, and vitamin K in the course of treatment with multiple mycobacterial agents in patients with tuberculosis with chronic liver disease]. D'Angelo G; Salatino A Clin Ter; 1970 Jan; 52(1):61-70. PubMed ID: 5525554 [No Abstract] [Full Text] [Related]
32. [The effect of a new hepatoprotective drug on bilirubinemia in geriatric age patients]. Baldoni E; Floris E; Nuzzo L G Gerontol; 1968 Aug; 16(8):789-92. PubMed ID: 5740954 [No Abstract] [Full Text] [Related]
33. [Clinical trial of liver-protective agents containing cytidine and uridine in the therapy of patients with liver diseases]. Grimaldi N; Santoro C Policlinico Med; 1971; 78(3):134-46. PubMed ID: 5568445 [No Abstract] [Full Text] [Related]
34. [Treatment of chronic liver diseases with vitamin B 12]. Wildhirt E Med Welt; 1965 Jul; 27():1489-92. PubMed ID: 5838530 [No Abstract] [Full Text] [Related]
35. [Therapeutic activity in the geriatric age of hepatic opotherapy in association with high doses of nucleosides]. Baldoni E; Floris E; Serenthà P; Negri U; Nuzzo L G Gerontol; 1968 Nov; 16(11):1261-99. PubMed ID: 5731973 [No Abstract] [Full Text] [Related]
36. [Clinical experience report on Hepavis]. Menninger U; Menninger W Med Welt; 1980 Oct; 31(42):1519-21. PubMed ID: 7453534 [No Abstract] [Full Text] [Related]
37. [Clinical study on the treatment of liver disease with glucocorticoids]. Oda T; Suzuki H; Naito C; Yamanada M; Oka H Saishin Igaku; 1969 Oct; 24(10):2119-29. PubMed ID: 5349229 [No Abstract] [Full Text] [Related]